GE HealthCare offers forecast-beating profit outlook after Q4 beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
GE HealthCare (GEHC) PT Raised to $91 at BTIG
February 4, 2026 12:33 PM ESTBTIG analyst Ryan Zimmerman raised the price target on GE HealthCare (NASDAQ: GEHC) to $91.00 (from $87.00) while maintaining a Buy rating.
The analyst comments "We maintain our Buy and raise our PT to $91 (from $87) following 4Q25 results. Order growth came in at ~2.0% with a Book-to-Bill ratio of 1.06x off a more challenging... More
